New drug added to brain surgery could reduce repeat operations
NCT ID NCT05491356
Summary
This study tested whether adding a clot-dissolving medication called tPA during a common brain surgery could improve outcomes for patients with chronic subdural hematomas (blood collections on the brain). The medication was given through the drainage catheter during surgery to help break down the blood clot, with the goal of reducing the need for repeat surgeries and shortening hospital stays. The study involved 40 adult patients who required this type of drainage procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOMA, SUBDURAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hamilton General Hospital
Hamilton, Ontario, L8L 2X2, Canada
Conditions
Explore the condition pages connected to this study.